• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名食管鳞状细胞癌患者奇静脉肿瘤血栓的清除。

Removal of tumor thrombus from the azygos vein in an esophageal squamous cell carcinoma patient.

作者信息

Lu Qijue, Shi Bowen, Hong Jiang, Chen Hezhong, Li Chunguang

机构信息

Department of Thoracic Surgery, Changhai Hospital, The Second Military Medical University, No. 168 Changhai Road, Shanghai, 200433, China.

出版信息

J Cardiothorac Surg. 2020 Mar 26;15(1):52. doi: 10.1186/s13019-020-01092-4.

DOI:10.1186/s13019-020-01092-4
PMID:32228632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7104544/
Abstract

BACKGROUND

Esophageal squamous cell carcinoma with tumor thrombus in the arch of the azygos vein has not been reported to date. Neoadjuvant chemotherapy can decrease the stage in patients with advanced preoperative tumor staging, regaining surgical opportunities and significantly prolonging progression-free survival and overall survival. Herein, we present a case of esophageal squamous cell carcinoma accompanied by tumor thrombus in the arch of the azygos vein, and the patient underwent radical surgery after neoadjuvant chemotherapy.

CASE PRESENTATION

A 63-year-old male with esophageal squamous cell carcinoma was found to have tumor thrombus formation in the arch of the azygos vein. Four courses of neoadjuvant chemotherapy with the TP regimen (paclitaxel plus nedaplatin) were given. Reexamination revealed a significant reduction in tumor and tumor thrombus volume. Therefore, McKeown radical resection for esophageal cancer and removal of the tumor thrombus in the arch of the azygos vein were performed. Postoperative pathology suggested complete remission of the esophageal tumor and the presence of small focal cancer tissues in the arch of the azygos vein.

CONCLUSION

We report a case of esophageal squamous cell carcinoma with tumor thrombus formation in the azygos vein. We conducted radical resection after 4 rounds of neoadjuvant chemotherapy, and the pathological results revealed complete remission of the tumor. We report our experience addressing this rare case, and we hope to find the underlying mechanism of tumor thrombus formation and whether it has any effects on prognosis in our future study.

摘要

背景

迄今为止,尚未见有关奇静脉弓内有肿瘤血栓形成的食管鳞状细胞癌的报道。新辅助化疗可降低术前肿瘤分期较晚患者的分期,使其重新获得手术机会,并显著延长无进展生存期和总生存期。在此,我们报告一例伴有奇静脉弓内肿瘤血栓形成的食管鳞状细胞癌病例,该患者在新辅助化疗后接受了根治性手术。

病例介绍

一名63岁的食管鳞状细胞癌男性患者被发现奇静脉弓内有肿瘤血栓形成。给予了4个疗程的TP方案(紫杉醇加奈达铂)新辅助化疗。复查显示肿瘤和肿瘤血栓体积显著缩小。因此,对该患者实施了食管癌McKeown根治性切除术,并切除了奇静脉弓内的肿瘤血栓。术后病理提示食管肿瘤完全缓解,奇静脉弓内存在小灶性癌组织。

结论

我们报告了一例奇静脉内有肿瘤血栓形成的食管鳞状细胞癌病例。我们在4轮新辅助化疗后进行了根治性切除,病理结果显示肿瘤完全缓解。我们报告了处理这一罕见病例的经验,并希望在未来的研究中找到肿瘤血栓形成的潜在机制及其对预后是否有任何影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5092/7104544/0cc27709cc6e/13019_2020_1092_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5092/7104544/8c9d0a1f959b/13019_2020_1092_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5092/7104544/81e09ebdb22c/13019_2020_1092_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5092/7104544/0cc27709cc6e/13019_2020_1092_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5092/7104544/8c9d0a1f959b/13019_2020_1092_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5092/7104544/81e09ebdb22c/13019_2020_1092_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5092/7104544/0cc27709cc6e/13019_2020_1092_Fig3_HTML.jpg

相似文献

1
Removal of tumor thrombus from the azygos vein in an esophageal squamous cell carcinoma patient.一名食管鳞状细胞癌患者奇静脉肿瘤血栓的清除。
J Cardiothorac Surg. 2020 Mar 26;15(1):52. doi: 10.1186/s13019-020-01092-4.
2
Study on the efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy regimen for III-IVA esophageal squamous cell carcinoma post-surgery.新辅助免疫治疗联合化疗方案用于Ⅲ-ⅣA期食管鳞状细胞癌术后的疗效与安全性研究
J Cardiothorac Surg. 2024 Jan 25;19(1):26. doi: 10.1186/s13019-024-02500-9.
3
Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.分析 SPARC 和 TUBB3 作为接受 nab-紫杉醇加顺铂新辅助化疗的食管鳞癌患者预后的预测因子:一项前瞻性研究。
Cancer Chemother Pharmacol. 2019 Apr;83(4):639-647. doi: 10.1007/s00280-019-03769-7. Epub 2019 Jan 14.
4
A rare case of azygos arch tumor thrombus in a patient with esophageal squamous cell carcinoma: A case report.1例食管鳞状细胞癌患者合并奇静脉弓肿瘤血栓形成的罕见病例:病例报告
Radiol Case Rep. 2024 May 11;19(8):3112-3117. doi: 10.1016/j.radcr.2024.04.002. eCollection 2024 Aug.
5
Neoadjuvant chemotherapy with irinotecan and nedaplatin in a single cycle followed by esophagectomy on cT4 resectable esophageal squamous cell carcinoma: a prospective nonrandomized trial for short-term outcomes.在可切除的 T4 期食管鳞癌中,采用伊立替康和顺铂进行单周期新辅助化疗后行食管切除术:短期结局的前瞻性非随机试验。
Dis Esophagus. 2019 Mar 1;32(3). doi: 10.1093/dote/doy080.
6
Short-term Outcomes of Adjuvant Nivolumab After Neoadjuvant Chemotherapy in Patients With Resected Esophageal Squamous Cell Carcinoma.新辅助化疗后辅助纳武利尤单抗治疗切除的食管鳞癌患者的短期结局。
Anticancer Res. 2024 Jan;44(1):185-193. doi: 10.21873/anticanres.16801.
7
Investigation of operative outcomes of thoracoscopic esophagectomy after triplet chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for advanced esophageal squamous cell carcinoma.三药化疗(多西他赛、顺铂和氟尿嘧啶)联合胸腔镜食管癌根治术治疗局部晚期食管鳞癌的疗效分析。
Surg Endosc. 2018 Jan;32(1):391-399. doi: 10.1007/s00464-017-5688-5. Epub 2017 Jun 29.
8
Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.临床III期食管鳞状细胞癌患者新辅助化疗与先行手术加或不加化疗的比较。
Dis Esophagus. 2017 Feb 1;30(2):1-8. doi: 10.1111/dote.12473.
9
Influence of Induction Therapy on Robot-Assisted McKeown Esophagectomy for Esophageal Squamous Cell Carcinoma.诱导治疗对机器人辅助 McKeown 食管癌根治术治疗食管鳞癌的影响。
Dig Surg. 2020;37(6):463-471. doi: 10.1159/000508965. Epub 2020 Jul 30.
10
Clinical significance of evaluating endoscopic response to neoadjuvant chemotherapy in esophageal squamous cell carcinoma.评估食管鳞癌新辅助化疗内镜反应的临床意义。
Dig Endosc. 2020 Jan;32(1):39-48. doi: 10.1111/den.13449. Epub 2019 Jul 17.

引用本文的文献

1
A rare case of azygos arch tumor thrombus in a patient with esophageal squamous cell carcinoma: A case report.1例食管鳞状细胞癌患者合并奇静脉弓肿瘤血栓形成的罕见病例:病例报告
Radiol Case Rep. 2024 May 11;19(8):3112-3117. doi: 10.1016/j.radcr.2024.04.002. eCollection 2024 Aug.
2
The Dilemma of Balance between Benefits and Losses for Chondromyxoid Fibroma-like Osteosarcoma in Thoracic Spine with Azygos Tumor Thrombosis: A Case Report.胸椎管内骨样黏液纤维瘤样骨肉瘤合并奇静脉肿瘤血栓形成的获益与损失平衡困境:1 例报告
Medicina (Kaunas). 2023 Apr 19;59(4):792. doi: 10.3390/medicina59040792.

本文引用的文献

1
Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus.局部进展期肾细胞癌合并肾静脉瘤栓的长期生存及预后因素。
BMC Cancer. 2019 Feb 13;19(1):144. doi: 10.1186/s12885-019-5359-0.
2
In-hospital Mortality after Surgical Resection in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus.肝细胞癌合并门静脉癌栓患者手术切除后的院内死亡率
J Cancer. 2019 Jan 1;10(1):72-80. doi: 10.7150/jca.27102. eCollection 2019.
3
Body mass index as an independent risk factor for inferior vena cava resection during thrombectomy for venous tumor thrombus of renal cell carcinoma.
体重指数作为肾细胞癌静脉瘤栓血栓切除术时切除下腔静脉的独立危险因素。
World J Surg Oncol. 2019 Jan 15;17(1):17. doi: 10.1186/s12957-019-1560-5.
4
Tailored treatment of patients with hepatocellular carcinoma with portal vein invasion: experience from a multidisciplinary hepatobiliary tumor program within a NCI comprehensive cancer center.门静脉侵犯的肝细胞癌患者的个体化治疗:来自美国国立癌症研究所综合癌症中心多学科肝胆肿瘤项目的经验
J Gastrointest Oncol. 2018 Dec;9(6):1074-1083. doi: 10.21037/jgo.2018.08.11.
5
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial.新辅助放化疗联合手术对比单纯手术治疗局部进展期食管鳞癌(NEOCRTEC5010):一项 III 期、多中心、随机、开放标签临床试验。
J Clin Oncol. 2018 Sep 20;36(27):2796-2803. doi: 10.1200/JCO.2018.79.1483. Epub 2018 Aug 8.
6
New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.肝细胞癌伴门静脉癌栓治疗的新证据与新视角
J Clin Transl Hepatol. 2017 Jun 28;5(2):169-176. doi: 10.14218/JCTH.2016.00071. Epub 2017 Mar 30.
7
A Collision Probability Model of Portal Vein Tumor Thrombus Formation in Hepatocellular Carcinoma.
PLoS One. 2015 Jul 1;10(7):e0130366. doi: 10.1371/journal.pone.0130366. eCollection 2015.
8
Postoperative radiotherapy improved survival of poor prognostic squamous cell carcinoma esophagus.术后放疗改善了预后不良的食管鳞癌患者的生存。
Ann Thorac Surg. 2010 Aug;90(2):435-42. doi: 10.1016/j.athoracsur.2010.04.002.